Generic Dexone depresses formation, release, and activity of endogenous mediators of inflammation, including prostaglandins, kinins, histamine, liposomal enzymes, and complement expression. Also modifies the body's immune response.
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept ... - MarketWatch (press release)
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept .
The Oncology Report Short List of Lymphoma and Multiple Myeloma Trials - The Oncology Report
The Oncology Report Short List of Lymphoma and Multiple Myeloma TrialsThe Oncology Report• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs.
Suspected illegal supply of Western medicine by Chinese medicine practitioner - 7thSpace Interactive (press release)
Suspected illegal supply of Western medicine by Chinese medicine practitioner7thSpace Interactive (press release)'The Government Laboratory's analysis results today detected the presence of dexamethasone and ketoconazole in a sample of the yellowish cream provided by the complainant, both of which could attain therapeutic levels if used in accordance with the .
Celgene announces three phase III Revlimid trials in newly diagnosed MM patients - pharmabiz.com
Celgene announces three phase III Revlimid trials in newly diagnosed MM patientspharmabiz.
New Multiple Myeloma Treatments On The Horizon (ASCO 2012) - The Myeloma Beacon
New Multiple Myeloma Treatments On The Horizon (ASCO 2012)The Myeloma BeaconSiltuximab is a compound that blocks the activity of IL-6, a protein that facilitates myeloma cell growth and resistance to dexamethasone (Decadron).